#Biotech
50 articles with this tag
Circular Genomics Secures $15 Million Series A for Alzheimer's Blood Test
AlphaFold Protein Prediction Reshapes APAC Research
AI gene editing platform aims to make CRISPR scalable
BioCLIP 2: A Biology Foundation Model for Ecosystem Insights
Generative Antibody Design Cracks 'Undruggable' Targets
Onepot AI Secures $13 Million to Revolutionize Chemical Synthesis for Drug Discovery
The Genomic LLM is here to decode 98% of human DNA
Modulight Secures $12 Million Seed Round for Light-Based Brain Therapy
Gina Raimondo: U.S. needs to lead in AI, quantum and biotech in order to win and outcompete China
\"In order to win and outcompete China, the U.S. needs to lead in AI, quantum, and biotech.
Gina Raimondo: U.S. needs to lead in AI, quantum and biotech in order to win and outcompete China
\"In order to win and outcompete China, the U.S. needs to lead in AI, quantum, and biotech.
Primaa raises €7M to advance AI cancer diagnostics
\n Biotech company Primaa has raised €7 million to expand its AI cancer diagnostics software.
Primaa raises €7M to advance AI cancer diagnostics
\n Biotech company Primaa has raised €7 million to expand its AI cancer diagnostics software.
Lilly Blackwell Drug Discovery: A New Era
Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge
Tahoe-x1 single cell model scales AI for cancer drug discovery
Valthos AI Biodefense Secures $30M to Combat Programmable Biology
Revyve Secures €24M Series B for Egg-Replacing Yeast Proteins
\n Revyve , a Dutch FoodTech scale-up, has secured €24 million in Series B funding. ABN AMRO Sustainable Impact Fund and Invest-NL co-led the round.
Revyve Secures €24M Series B for Egg-Replacing Yeast Proteins
\n Revyve , a Dutch FoodTech scale-up, has secured €24 million in Series B funding. ABN AMRO Sustainable Impact Fund and Invest-NL co-led the round.
Biotech's AI Infusion: A Tremendous Opportunity
Synthesize Bio Raises $10M Seed for Generative Genomics
Synthesize Bio raised $10M for generative genomics. Its GEM-1 model accelerates drug discovery.
Terra Oleo Secures $3.1M for Sustainable Oil Production
Singapore-based Terra Oleo has secured $3.1 million in funding to advance its sustainable oil production technology. ADB Ventures, Better Bite Ventures, Elev8.
Terra Oleo Secures $3.1M for Sustainable Oil Production
Singapore-based Terra Oleo has secured $3.1 million in funding to advance its sustainable oil production technology. ADB Ventures, Better Bite Ventures, Elev8.
Virtual Cells: Unlocking Biology's Latent Speed with AI
Ridge Bio Secures $25M Seed for AI-Enabled Drug Design
GPT-5 Ignites Moderna's Second Computing Revolution
NRG Therapeutics Secures £50M Series B for ALS, Parkinson's Drugs
NRG Therapeutics secured £50 million in Series B funding, led by SV Health Investors’ Dementia Discovery Fund. This investment will advance mitochondrial-targeting treatments for neurodegenerative diseases. The company aims to transition its pipeline, including lead candidate NRG5051 for ALS and Parkinson's, into...
BoobyBiome Secures €2.8M Seed for Infant Health Solutions
\n London-based biotech firm BoobyBiome has raised €2.8 million in Seed funding. DeepTech investor Empirical Ventures led the round, supporting the company\'s a...
BoobyBiome Secures €2.8M Seed for Infant Health Solutions
\n London-based biotech firm BoobyBiome has raised €2.8 million in Seed funding. DeepTech investor Empirical Ventures led the round, supporting the company\'s a...
Enveda Secures $150M Series D, Achieves Unicorn Status
Treeline Biosciences Raises $200M, Initiates Clinical Trials
The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.
Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies
Northern Ireland-based biotech startup Dia Beta Labs has secured €1.4 million in funding.
Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies
Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.
British EnsiliTech Secures €5.2M Seed for Cold-Chain Biopharma
Bristol-based EnsiliTech secured €5.2 million in Seed funding. Eos Advisory led the round, aiming to transform global biopharma transport.
British EnsiliTech Secures €5.2M Seed for Cold-Chain Biopharma
EnsiliTech secured €5.2 million in Seed funding, led by Eos Advisory. This capital will advance its patented Ensilication technology, which stabilizes biopharmaceuticals at higher temperatures. The innovation aims to eliminate cold-chain reliance, revolutionizing global biopharma transport.
German Detechgene Secures €3.2M for Mobile Lab Diagnostics
Cologne-based biotech startup Detechgene raised €3.2 million in its second Seed round. Neoteq ventures led the investment.
German Detechgene Secures €3.2M for Mobile Lab Diagnostics
German biotech Detechgene secured €3.2 million in its second Seed round, led by Neoteq ventures. The company develops 'PCR to Go', a mobile platform for fast, lab-accurate molecular diagnostics. This funding will commercialise its platform, advancing decentralized healthcare diagnostics.
AMD Ventures Backs Somite.ai with Strategic Investment to Accelerate Foundation Models for Cell Therapy
\n Somite.ai , a company developing foundation models for human stem cells, announced on August 20, 2025, that it has received a strategic investment from AMD V...
AMD Ventures Backs Somite.ai with Strategic Investment to Accelerate Foundation Models for Cell Therapy
\n Somite.ai , a company developing foundation models for human stem cells, announced on August 20, 2025, that it has received a strategic investment from AMD V...
Oxford's SugaROx Secures €1.1M for Biostimulant Scale-Up
Oxford's SugaROx secured €1.1 million in a seed round extension. The Mosaic Company led this funding round, contributing £400k. This investment accelerates the development and production of its crop-enhancing biostimulants.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Zurich-based Mabylon , a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.
Tahoe Therapeutics Raises $30M for AI Human Cell Models
Tahoe Therapeutics secured $30 million in new funding. Amplify Partners led the round. This capital will fuel the creation of AI models of human cells to advance drug discovery.
Latvian Cellbox Labs Lands €3.3M for Organ-on-Chip Innovation
Latvian Cellbox Labs secured €3.3 million in non-dilutive funding. This capital, partly from the IPCEI “Tech4Cure” initiative, supports its organ-on-chip technology development. The investment aims to advance drug discovery and reduce reliance on animal testing.
Latvian Cellbox Labs Lands €3.3M for Organ-on-Chip Innovation
\n Riga-based Cellbox Labs secured €3.3 million in non-dilutive funding. This capital, partly from the Important Project of Common European Interest (IPCEI) “Te...
SNIPR Biome Secures €35M Series B for CRISPR Therapies
SNIPR Biome, a Danish biotech, secured €35 million in Series B funding. New investors Cystic Fibrosis Foundation and SPRIN-D joined the round, alongside existing backers. This capital will advance its microbial CRISPR-medicine development, including therapies for cystic fibrosis and antimicrobial resistance.
SNIPR Biome Secures €35M Series B for CRISPR Therapies
Copenhagen-based SNIPR Biome , a Danish biotech scale-up, secured €35 million in Series B funding.
Chai Discovery Secures $70M for AI Drug Development
AI drug development startup Chai Discovery has raised $70 million in a Series A round led by Menlo Ventures. The new capital will be used to advance its AI platform and pursue previously inaccessible drug targets. As part of its expansion, former Pfizer Chief Scientific Officer Mikael Dolsten is joining the company'...
Lithuanian Psylink Secures €500k for Mental Health BioTech
Vilnius-based Psylink secured over €500k in a pre-Seed funding round led by Coinvest Capital.
Lithuanian Psylink Secures €500k for Mental Health BioTech
Vilnius-based Psylink secured over €500k in a pre-Seed funding round led by Coinvest Capital.
